EuBiologics Co., Ltd.
206650.KQFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
72
Cost of Revenue
30
Gross Profit
42
Gross Margin
58.3%
Operating Income
26
Operating Margin
35.7%
Net Income
14
Net Margin
19.8%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
22
EBITDA Margin
30.9%
2023
12/31/2023
Revenue
52
Cost of Revenue
27
Gross Profit
25
Gross Margin
49.0%
Operating Income
6
Operating Margin
11.1%
Net Income
-10
Net Margin
-20.0%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-3
EBITDA Margin
-6.3%
2022
12/31/2022
Revenue
42
Cost of Revenue
25
Gross Profit
17
Gross Margin
40.1%
Operating Income
-3
Operating Margin
-6.8%
Net Income
-1
Net Margin
-2.0%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
4
EBITDA Margin
9.7%
2021
12/31/2021
Revenue
30
Cost of Revenue
19
Gross Profit
11
Gross Margin
36.2%
Operating Income
-5
Operating Margin
-18.4%
Net Income
-21
Net Margin
-70.0%
EPS (Basic)
$-1.00
EPS (Diluted)
$-1.00
EBITDA
-17
EBITDA Margin
-59.1%
2020
12/31/2020
Revenue
21
Cost of Revenue
17
Gross Profit
5
Gross Margin
21.5%
Operating Income
-4
Operating Margin
-20.9%
Net Income
-45
Net Margin
-211.1%
EPS (Basic)
$-2.00
EPS (Diluted)
$-2.00
EBITDA
-39
EBITDA Margin
-184.3%